Page 122 - MEMORIA ANUAL 2021

MEMORIA ANUAL 2021 SOCIEDAD ESPAÑOLA DE
HEMATOLOGÍA Y HEMOTERAPIA
GESMD
FUNDACIÓN ESPAÑOLA DE HEMATOLOGÍA Y HEMOTERAPIA
García-Gisbert N, Arenillas L, Román-Bravo D, Rodríguez-Sevilla JJ, Merchán B, García- Ávila S, Fernández-Rodríguez C, Gibert J, Salar A, Bellosillo B, Ferrer A, Calvo X .
• Non-Invasive Genetic Profiling and Monitoring in Myelodysplastic Syndromes.
63rd ASH Annual Meeting. Blood. 2021;138(Supplement 1):2599. https://doi.org/10.1182/ blood-2021-148297.
García-Gisbert N, Merchán B, García-Ávila S, Salido M, Fernández-Rodríguez C, Gibert J, Fernández-Ibarrondo L, Camacho L, Lafuente M, Longarón R, Espinet B, Vélez P, Andra- de-Campos MM, Pujol RM, Arenillas L, Calvo X, Besses C, Salar A, Bellosillos B .
• Clinical Outcomes of Oligomonocytic Chronic Myelomonocytic Leukemia (OM-CM- ML) and Predictive Factors of Evolution of OM-CMML into Overt Chronic Myelomono- cytic Leukemia (CMML).
63rd ASH Annual Meeting. Blood. 2021;138(Supplement 1):1533. https://doi.org/10.1182/ blood-2021-146447.
Román-Bravo D, Arenillas L, Asensi MT, García-Gisbert N, Rodríguez-Sevilla JJ, Merchán B, García Ávila S, Bellosillo B, Fernández-Rodríguez C, Florensa L, Ferrer A, Calvo X .
• Interobserver Variability with the Diagnosis of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS). Is the Threshold of 20% Bone Marrow Blasts Re- producible?
63rd ASH Annual Meeting. Blood. 2021;138(Supplement 1):2607. https://doi.org/10.1182/ blood-2021-149147.
Font López P, Loscertales J, López Rubio M, Cedena MT, Soto C, Seri C, Ricard P, Balles- teros M, Benavente C, Piris-Villaespesa M, Muñoz C, García Alonso L, Bermejo A, Pérez Segura G, Gómez Rojas S, Castilla L, Jiménez Chillón C, Ortuzar A, Bellón JM, Villarrubia J, Diez-Martin JL, Villegas A .
• Uncovering perturbations in human hematopoiesis associated with healthy aging and myeloid malignancies at single cell resolution.
EHA Virtual Congress 2021.
Chen-Liang TH, Carrillo-Tornel S, Hurtado AM, Santiago M, Such E, Palomo L, Rodríguez- Gil MA, Jiménez MJ, del Orbe R, López-Cadenas F, Tormo M, Hermosín L, Bernal T, Salido E, Benet C, Muiña B, Oña R, de Haro N, Ramos F, Ortuño FJ, Senent L, Tuset E, Pomares H, Martínez-Francés A, Arquero T, Montoro J, Teruel-Montoya R, Cervera J, Valcárcel D, Arnán M, Arrizabalaga B, Díez-Campelo M, Xicoy B, Hernández F, Solé F, Sanz G, Jerez A .
• Analysis of germline predisposition in patients with myeloid neoplasms: association between molecular alterations and clinical history.
122